A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

NCT02078102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Non-Hodgkin's Lymphoma

Interventions

DRUG: Meloxicam
DRUG: Filgrastim

Sponsor

Sherif S. Farag

Collaborators

[object Object]